As expected, the Runx genes (Runx2 and Runx3) and Myc family targets (Myc, Mycn) conformed to this pattern, being selected in CD2-MYC and CD2-Runx2 respectively and effectively disappearing from the double transgenic tumours (Figure 4C). The gene discussed is CD2; the disease is neoplasm.